Christian B. Fulda

Christian B. Fulda

Metropolregion München
1587 Follower:innen 500+ Kontakte

Info

I am a life sciences lawyer. I advise biotech, pharma and medtech companies and help them…

Aktivitäten

Anmelden, um alle Aktivitäten zu sehen

Berufserfahrung

Ausbildung

  • Humboldt-Universität zu Berlin Grafik

    Humboldt University of Berlin

    -

    Doctoral thesis under the auspices of Prof. Dr. Christian Tomuschat at the Institute for Public International Law and European Law of Humboldt University on democracy and international contracts.

  • -

    German Elite Scholarship

  • -

Veröffentlichungen

  • Commercially Confidential Information at Risk: The European Medicines Agency Issues Disclosure Policy

    Jones Day Client Alert

    As if the fight for reasonable returns on investment into drug development, currently exemplified by the discussion on the pricing of innovative products, is not enough, the pharmaceutical industry is facing one of its biggest challenges in Europe: the protection of commercially confidential information ("CCI") contained in the marketing authorization dossier, the DNA of a product.

    This Alert discusses the "Policy on Publication of Clinical Data for Medicinal Products for Human Use"…

    As if the fight for reasonable returns on investment into drug development, currently exemplified by the discussion on the pricing of innovative products, is not enough, the pharmaceutical industry is facing one of its biggest challenges in Europe: the protection of commercially confidential information ("CCI") contained in the marketing authorization dossier, the DNA of a product.

    This Alert discusses the "Policy on Publication of Clinical Data for Medicinal Products for Human Use" adopted by the European Medicines Agency ("EMA") on October 2, 2014. It also summarizes the action points that industry should take to safeguard its investments in drug development.

    Veröffentlichung anzeigen

Projekte

  • Dec 4, 2014: JD Webinar on EMA Disclosure of Marketing Authorization Data

    The European Medicines Agency (EMA) has adopted a new policy on the publication of clinical data, effective for all marketing authorization applications filed as of January 1, 2015. Christian Fulda, of Jones Day's Intellectual Property Practice in Munich, will discuss how the policy requires a fundamental change in process regarding filings in Europe in order to protect commercially confidential data.

    Projekt anzeigen

Sprachen

  • German

    Muttersprache oder zweisprachig

  • English

    Verhandlungssicher

  • French

    Fließend

  • Italian

    Gute Kenntnisse

  • Spanish

    Gute Kenntnisse

Weitere Aktivitäten von Christian B. Fulda

Christian B. Fuldas vollständiges Profil ansehen

  • Herausfinden, welche gemeinsamen Kontakte Sie haben
  • Sich vorstellen lassen
  • Christian B. Fulda direkt kontaktieren
Mitglied werden. um das vollständige Profil zu sehen

Weitere ähnliche Profile

Entwickeln Sie mit diesen Kursen neue Kenntnisse und Fähigkeiten